Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ninan T Mathew

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Headache|November 25, 2003
Early intervention with almotriptan improves sustained pain-free response in acute migraineNinan T Mathew
Headache|April 23, 2002
Almotriptan increases pain-free status in patients with acute migraine treated in placebo-controlled clinical trialsNinan T Mathew
Clinical Therapeutics|May 23, 2002
Use of rescue medication in trials of almotriptan versus placebo in the treatment of acute migraineNinan T Mathew
European Neurology|May 28, 2005
Efficacy and tolerability of almotriptan in controlled clinical trialsNinan T Mathew
Headache|November 23, 2006
The prophylactic treatment of chronic daily headacheNinan T Mathew
Handbook of Clinical Neurology|September 7, 2010
Cluster headache and other trigeminal autonomic cephalalgias diagnostic criteriaNinan T Mathew
Neurology|February 4, 2009
Dynamic optimization of chronic migraine treatment: current and future optionsNinan T Mathew
Current Neurology and Neuroscience Reports|March 9, 2006
Tension-type headacheNinan T Mathew
Headache|May 15, 2002
A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraineNinan T Mathew,
Headache|July 21, 2011
Pathophysiology of chronic migraine and mode of action of preventive medicationsNinan T Mathew
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Headache|November 25, 2003
Early intervention with almotriptan improves sustained pain-free response in acute migraineNinan T Mathew
Headache|April 23, 2002
Almotriptan increases pain-free status in patients with acute migraine treated in placebo-controlled clinical trialsNinan T Mathew
Clinical Therapeutics|May 23, 2002
Use of rescue medication in trials of almotriptan versus placebo in the treatment of acute migraineNinan T Mathew
European Neurology|May 28, 2005
Efficacy and tolerability of almotriptan in controlled clinical trialsNinan T Mathew
Headache|November 23, 2006
The prophylactic treatment of chronic daily headacheNinan T Mathew
Handbook of Clinical Neurology|September 7, 2010
Cluster headache and other trigeminal autonomic cephalalgias diagnostic criteriaNinan T Mathew
Neurology|February 4, 2009
Dynamic optimization of chronic migraine treatment: current and future optionsNinan T Mathew
Current Neurology and Neuroscience Reports|March 9, 2006
Tension-type headacheNinan T Mathew
Headache|May 15, 2002
A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraineNinan T Mathew,
Headache|July 21, 2011
Pathophysiology of chronic migraine and mode of action of preventive medicationsNinan T Mathew
Pageof 4